Page 14 - Pharma Stocks

Wanbury surges 5% after USFDA issues Zero observations for Patalganga site

At 9:55 AM, the shares were off highs, trading 2.25 per cent higher at Rs 163.95 per share. In comparison, BSE Sensex was trading 0.16 per cent lower at 77,211.40 levels.

Suven Pharma stock rises 6% on nod to acquire Sapala Organics for Rs 230 cr

The surge came after Suven Pharmaceuticals said that it has entered into a definitive agreement to acquire a controlling stake of Sapala Organic for Rs 229.5 crore, in an all cash deal

Venus Remedies up 8% on order win from UNICEF for bacterial infection drug

The uptick in stock price came after the company announced that it has secured an award for its antibiotic product, Ceftriaxone 1 gm, from UNICEF

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit

The fall came after the United States Food and Drug Administration (USFDA) issued a Form 483 with five observations for the Indrad unit

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Among individual players, Aurobindo Pharma, Dr Reddys Labs, and Zydus Lifesciences sourced 48 per cent, 47 per cent, and 46 per cent of their total revenues from the US generics segment, respectively

Pharma stocks in focus; Astrazeneca, Glenmark, Divi's, Torrent soar upto 9%

Torrent Pharma hits a new high of Rs 2,839.90, surging 9% in the intraday trade after the company reported a strong 56% Y-o-Y jump in Q4 profit

Stock trading guide for today: How to approach pharma, FMCG counters?

Technical indicators such as the RSI, MACD, and Stochastic are showing signs of potential correction and underperformance for the Nifty Pharma index

Zydus Lifesciences stock rallies 5%; hits record high on robust Q4 results

EBITDA margin for the quarter stood at 29.5 per cent, an improvement of 440 bps on a YoY basis.

Investment idea: Motilal Oswal bullish on Sun Pharma; check outlook, upside

Sun Pharma, the brokerage said, is building an interesting specialty pipeline (under development) for addressing patient's needs in areas of dermatology, ophthalmology, and onco-dermatology

Suven Pharma stock can surge up to 19% from here; check key levels

Technical charts suggest that Suven Pharma may trade with a positive bias in the near-term, provided the stock manages to hold above these key support levels.

SMS Pharma soars 16% on positive biz outlook; zooms 60% so far in 2024

The stock is now seen trading close to its 52-week and all-time high registered in March 2024 and August 2021, respectively.

Suven Pharma soars 13% on announcing merger of Cohance Lifesciences

As per the amalgamation arrangement, Cohance shareholders to get 11 shares of Suven for every 259 shares of Cohance held by them.

Moderation in earnings growth may weigh on equities this year: Vinit Sambre

Sambre says while equities may do well in the long-term, it would be prudent for investors to reassess their asset allocation and bring it in line with their risk profile

Moderna reports surprise Q4 profit, sets out road map for RSV vaccine

Moderna recorded $6.8 billion in sales from its COVID vaccine in 2023, down from $18.4 billion in 2022 but slightly above Wall Street estimates of $6.7 billion

Medplus slips 2% after board defers expansion plan of diagnostics division

The company's board on Wednesday decided to defer the expansion plans for Diagnostics Division beyond Hyderabad, until the profitability of the pilot project was established.

Novartis soars 11%; board to support parent firm explore strategic options

According to reports, Dr Reddy's Laboratories is likely in a race to acquire Novartis AG's stake in Novartis India.

This Mukul Agrawal-owned pharma stock has zoomed over 200% in 9 months

Neuland Lab hit a new high of Rs 6,910, rallied 6% after reported robust earnings with profit after tax more than doubled to Rs 80.7 crore in Q3FY24, on back of healthy operational performance.

Lupin soars 7%, trades at highest level since Aug 2016 on strong Q3 results

The company's profit jumped nearly 300 per cent to Rs 613 crore for the December 2023 quarter from a year ago period.

Sun Pharma Advanced Research freezes at 10% upper circuit; up 64% in 8 days

In the medium term, SPARC's pipeline has several inflexion points that can drive significant value for the company.

Stock of this pharma company has nearly doubled against its issue price

Mankind hit record high of Rs 2,132.10, rallied 8% in intra-day trade and zoomed 97% against its issue price of Rs 1,080 per share.